Needham Maintains a Buy Rating on CorMedix (CRMD) With a $20 PT
CorMedix Inc. (NASDAQ:CRMD) is one of the top most undervalued biotech stocks to buy now. On August 7, Needham analyst Serge Belanger maintained a Buy rating on CorMedix Inc.
Cormedix Inc. (CRMD)
Market is closed
Hedge Fund Popularity
Hedge Fund Holdings
Filing Period:
Last updated on based on SEC 13F filings Last update:
| No. | Hedge Fund | Shares | Value | Activity | % Port |
|---|---|---|---|---|---|
| 1. | Marshall Wace LLP Paul Marshall And Ian Wace | 2,579,976 | $31,785,302 | +1020% | 0.04% |
| 2. | Citadel Investment Group Ken Griffin | 1,714,215 | $21,119,129 | +1518% | 0% |
| 3. | Alyeska Investment Group Anand Parekh | 750,000 | $9,240,000 | 0.03% | |
| 4. | Ghisallo Capital Management Michael Germino | 750,000 | $9,240,000 | 0.25% | |
| 5. | Anson Investments Amin Nathoo And Moez Kassam | 725,000 | $8,932,000 | 1.29% |
Insider Trading: Purchases See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $9.99 | 1,500 | $14,984.85 | 52,011 | 2024-10-31 | Filing | |
| $3.74 | 13,561 | $50,718.14 | 352,839 | 2024-03-13 | Filing | |
| $3.30 | 3,000 | $9,900.00 | 15,250 | 2023-12-15 | Filing | |
| $3.45 | 3,000 | $10,350.00 | 12,250 | 2023-12-14 | Filing | |
| $4.00 | 1,000 | $4,000.00 | 4,900 | 2023-11-17 | Filing |
Insider Trading: Sales See All
| Insider | Price | Amount | Total Value | Remaining Holdings | Date | Form 4 |
|---|---|---|---|---|---|---|
| $11.18 | 140,027 | $1,565,669.89 | 45,397 | 2024-11-14 | Filing | |
| $6.92 | 8,000 | $55,393.60 | 0 | 2021-05-21 | Filing | |
| $2.00 | 10,000 | $20,000.00 | 0 | 2017-02-07 | Filing | |
| $2.23 | 20,000 | $44,600.00 | 0 | 2016-10-21 | Filing | |
| $2.21 | 819 | $1,811.79 | 0 | 2016-06-21 | Filing |
Institutional Investors' Holdings
Filing Period:
| No. | Name | Shares | Value | % Port |
|---|---|---|---|---|
| 1. | 5,359,829 | $66,033,094 | 0% | |
| 2. | 4,325,545 | $53,290,715 | 0% | |
| 3. | 1,601,648 | $19,732,303 | 0% | |
| 4. | 1,596,322 | $19,669,065 | 0% | |
| 5. | 1,468,721 | $18,094,643 | 0.01% |
News See All
CorMedix Inc. (NASDAQ:CRMD) Q2 2025 Earnings Call Transcript
Operator: Good day, and welcome to the CorMedix Inc. Second Quarter 2025 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
10 Most Undervalued Biotech Stocks to Buy Now
On July 25, Salveen Richter, Goldman Sachs' lead biotech analyst, appeared on CNBC’s ‘Squawk Box’ to talk about the state of the biotech sector and what to expect from the earnings season, among...
CorMedix Inc. (CRMD): A Bull Case Theory
We came across a bullish thesis on CorMedix Inc. (CRMD) on Archetype Capital’s Substack. In this article, we will summarize the bulls’ thesis on CRMD. CorMedix Inc.
Billionaire Paul Singer's 10 Stock Picks with Huge Upside Potential
Paul Singer founded Elliott Investment Management in 1977 in New York. It is one of the oldest hedge funds under continuous management and is also one of the largest activist funds in the world.
CorMedix Inc. (NASDAQ:CRMD) Q1 2025 Earnings Call Transcript
Operator: Good day and welcome to the CorMedix, Inc. First Quarter 2025 Financial Results Conference Call. All participants will be in listen-only mode.
CorMedix Inc. (NASDAQ:CRMD) Q4 2024 Earnings Call Transcript
Operator: Good day and welcome to the CorMedix Inc. Fourth Quarter and Full Year 2024 Financial Results Conference Call. All participants will be in listen-only mode.
Billionaire Paul Singer's Top 12 Long-Term Stock Picks
The world's "most feared investor," Paul Singer, needs no introduction.
CorMedix Inc. (NASDAQ:CRMD) Q3 2024 Earnings Call Transcript
Operator: Good day and welcome to the CorMedix Inc. Third Quarter 2024 Financial Results Conference Call. [Operator Instructions] Please note this event is being recorded.
CorMedix Inc. (CRMD): A Bull Case Theory
We came across a bullish thesis on CorMedix Inc. (CRMD) on ValueInvesting subreddit page by gamblingPharmaStocks. In this article, we will summarize the bulls’ thesis on CRMD. CorMedix Inc.